Penumbra (PEN) EBIT Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.21% |
| Dec 31, 2025 | 104.70% |
| Sep 30, 2025 | 34.63% |
| Jun 30, 2025 | 33.96% |
| Mar 31, 2025 | 131.26% |
| Dec 31, 2024 | 32.24% |
| Sep 30, 2024 | 22.20% |
| Jun 30, 2024 | -52.78% |
| Mar 31, 2024 | 1.65% |
| Dec 31, 2023 | 39.34% |
| Sep 30, 2023 | 21.11% |
| Jun 30, 2023 | 14.02% |
| Mar 31, 2023 | 14.64% |
| Dec 31, 2022 | 4.62% |
| Sep 30, 2022 | 51.40% |
| Jun 30, 2022 | 36.33% |
| Mar 31, 2022 | -14.61% |
| Dec 31, 2021 | -103.35% |
| Sep 30, 2021 | 53.21% |
| Jun 30, 2021 | 77.04% |
| Mar 31, 2021 | 48.97% |
| Dec 31, 2020 | -24.23% |
| Sep 30, 2020 | -62.23% |
| Jun 30, 2020 | -35.86% |
| Mar 31, 2020 | -31.31% |
| Dec 31, 2019 | 101.06% |
| Sep 30, 2019 | 110.90% |
| Jun 30, 2019 | -9.16% |
| Mar 31, 2019 | -8.57% |